当前位置: X-MOL 学术Am. J. Bioethics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?
The American Journal of Bioethics ( IF 17.0 ) Pub Date : 2020-03-24
Liza-Marie Johnson, Devan M. Duenas, Benjamin S. Wilfond

(2020). Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies? The American Journal of Bioethics: Vol. 20, No. 4, pp. 111-113.

中文翻译:

罕见儿童疾病的伦理药物开发:如果成人的数据有限但前景广阔,如何在安全性或功效研究之间进行选择?

(2020)。罕见儿童疾病的伦理药物开发:如果成人的数据有限但前景广阔,如何在安全性或功效研究之间进行选择?美国生物伦理学杂志:第一卷。20,第4号,第111-113页。
更新日期:2020-03-24
down
wechat
bug